Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.
There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive decline, according to a new study presented today at the annual meeting of the Radiological Society of ...
Minute traces of gadolinium, the contrast agent used to enhance MR images, are often retained in the brain tissue of patients years after undergoing MRI. Some studies have suggested this deposition ...
Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
The rate of hypersensitivity reactions (HSRs) to gadolinium-based contrast agents (GBCAs) is 0.4 percent, and premedication can reduce the risk for HSRs in patients with a history of acute or delayed ...
CHALFONT ST GILES, England--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE ...
(Reuters Health) - Women who don't realize they're pregnant when they undergo magnetic resonance imaging (MRI) may be exposed to a chemical that might not be safe for the fetus, a new report warns.
Simulations reveal details about the magnetic interactions between gadolinium contrast agents used in MRI scans and their environment. You can keep your best guesses. Engineers at Rice University's ...
There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive decline, according to a new study. There is no evidence that accumulation in the brain of the element ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results